AI-generated summary
The authors conducted a systematic review of 10 selected clinical studies on treating severe alopecia areata in children with topical immunotherapy, Anthralin, or low-level light/laser therapy. They report that topical immunotherapy and light/laser therapy showed higher hair regrowth rates than Anthralin, with no serious side effects observed. The authors note that the evidence base is limited, and that a combination approach could be suggested for extensive cases.
- Studies included
- 10
- Who or what was studied
- Children with severe or extensive alopecia areata
- Limits stated in the abstract
- The abstract does not report a total participant count, and the included studies' designs and quality are not described in detail.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Systematic review, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.